Magnolia Medical Technologies Email Format

Medical Equipment ManufacturingWashington, United States51-200 Employees

Magnolia Medical Technologies is a medical equipment manufacturer based in Seattle, Washington, focused on reducing diagnostic errors in bloodstream infection testing. Its Steripath Initial Specimen Diversion Device platform targets contamination during specimen collection to prevent misdiagnosis of sepsis and false-positive catheter-related bloodstream infections, with the goal of avoiding unnecessary antibiotic therapy. The company emphasizes evidence-based technology and aims to support changes in clinical practice to improve patient outcomes and reduce costs tied to diagnostic errors.

The firm maintains a sizable intellectual property portfolio, including more than 100 issued patents and over 70 patent applications, to address critical gaps in in vitro diagnostics. Its customers are healthcare institutions seeking greater diagnostic accuracy and antimicrobial stewardship, and it has pursued partnerships to broaden its reach, such as a collaboration with Becton Dickinson to co-sell and co-market Steripath products. In February 2026 Magnolia appointed Sarah Huber as Senior Vice President of Sales to lead its commercial efforts.

Get verified Magnolia Medical Technologies emails free

Company overview Employee directory